Research programme: tuberculosis vaccines - Aeras/China National Biotec Group
Latest Information Update: 04 Sep 2013
At a glance
- Originator Aeras Global TB Vaccine Foundation; China National Biotec Group
- Developer Aeras; China National Biotec Group
- Class Tuberculosis vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Research Tuberculosis